Reference interval and the role of plasma oligomeric beta amyloid in screening of risk groups for cognitive dysfunction at health checkups
Background: Alzheimer's disease (AD) has a prolonged preclinical stage characterized by cognitive dysfunction. Simple, reliable, and noninvasive biomarkers reflecting the pathogenesis of AD are needed for screening cognitive dysfunction in primary health care. The aims of this study were to det...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
John Wiley and Sons Inc
2021
|
Subjects: | |
Online Access: | View Fulltext in Publisher |